| Title | Journal | Date | Pubmed ID |
|---|---|---|---|
| r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement. | Neurochem Res | 2015 Oct | 26227997 |
| bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse. | Br J Pharmacol | 2011 May | 21232049 |